Crispr Therapeutics shares owned by Geode Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $47M | 1.0M | 47.00 |
| 2024-06-30 | $53M | 973k | 54.03 |
| 2024-03-31 | $62M | 909k | 68.18 |
| 2023-09-30 | $39M | 850k | 45.40 |
| 2023-06-30 | $47M | 835k | 56.14 |
| 2023-03-31 | $37M | 810k | 45.23 |
| 2022-12-31 | $32M | 789k | 40.65 |
| 2022-09-30 | $50M | 765k | 65.35 |
| 2022-06-30 | $43M | 714k | 60.77 |
| 2022-03-31 | $42M | 663k | 62.77 |
| 2021-12-31 | $5.0M | 66k | 75.77 |
| 2021-09-30 | $7.2M | 65k | 111.92 |
| 2021-06-30 | $10M | 64k | 161.88 |
| 2021-03-31 | $7.8M | 64k | 121.84 |
| 2020-12-31 | $8.0M | 53k | 153.10 |
| 2020-09-30 | $4.3M | 51k | 83.63 |
| 2020-06-30 | $3.5M | 47k | 73.48 |
| 2020-03-31 | $1.8M | 43k | 42.40 |
| 2019-12-31 | $2.4M | 39k | 60.90 |
| 2019-09-30 | $1.6M | 39k | 40.99 |
| 2019-06-30 | $1.8M | 39k | 47.08 |
| 2019-03-31 | $1.4M | 39k | 35.71 |
| 2018-12-31 | $999k | 35k | 28.56 |
| 2018-09-30 | $1.6M | 36k | 44.33 |
| 2018-06-30 | $2.1M | 36k | 58.74 |
| 2018-03-31 | $1.3M | 28k | 45.69 |
| 2017-12-31 | $633k | 27k | 23.45 |
| 2017-09-30 | $472k | 26k | 17.87 |
| 2017-06-30 | $294k | 18k | 15.99 |
| 2017-03-31 | $459k | 21k | 21.74 |
| 2016-12-31 | $371k | 18k | 20.22 |